GLOSSARY

Clinical Cardiovascular Nutrition adapts nutrition to cardiovascular disease, risk and indicated treatment.

Cardiovascular risk reflects multiple factors, including lipids, blood pressure, smoking, glycemic status and medical history. Atherosclerosis concerns plaque-related arterial disease, while cardiovascular disease includes a broader range of conditions. Dietary patterns can support prevention and treatment but do not replace urgent assessment of new chest pain, stroke symptoms or other acute warning signs. An athlete's fitness does not establish absence of disease. Coordinate exercise and nutrition decisions with the relevant clinical assessment when cardiovascular disease is suspected or established.

Cardioprotective eating commonly emphasizes vegetables, fruit, legumes, whole grains, nuts and suitable unsaturated-fat sources while improving the quality of fat and reducing excessive sodium. Benefits depend on what replaces the foods reduced. Clinical lipid and blood-pressure goals require broader assessment, including medication when indicated. Athletes should adapt portions and carbohydrate supply to training rather than assuming a heart-supporting pattern must be low in energy, extremely restrictive or unsuitable for fueling exercise.

Lipid management distinguishes LDL cholesterol, triglycerides, non-HDL cholesterol and other relevant markers rather than treating every abnormal result as the same problem. Dietary fat quality, fiber-containing foods, alcohol, energy balance and underlying conditions can affect different components. Medication may also be indicated according to overall cardiovascular risk. A high HDL value does not cancel elevated atherogenic risk, and changing one laboratory number does not by itself demonstrate improved clinical outcomes or superior athletic performance.

Blood pressure assessment depends on appropriate measurement and repeated interpretation, not one anxious or post-exercise reading. Sodium reduction and a suitable dietary pattern can help management, while potassium advice must account for kidney function and medication. Salt substitutes containing potassium are not suitable for everyone. An athlete's sweat-related electrolyte plan and a clinical hypertension plan require coordination. Do not assume that sweating heavily eliminates the need to assess persistent high blood pressure or prescribed treatment.

Clinical nutrition translates assessment into an individualized intervention and evaluates the response. A disease name alone cannot define the prescription: disease stage, medication, symptoms, laboratory findings, intake and functional goals matter. Screening identifies possible risk, whereas a full assessment supports a nutrition diagnosis and care plan. A sports context adds training demands but does not remove clinical requirements. Coordinate care when medical and performance objectives interact instead of applying a standard athlete menu to every patient.

Nutrition follow-up compares intended goals with actual intake, symptoms, function, relevant measurements and the person's experience. Specify the time frame and what would justify adjustment, continuation or referral. A treatment response can be beneficial, absent or adverse, and adherence alone does not prove effectiveness. Retain enough documentation to understand what changed. For an athlete, consider health and training quality alongside body mass or laboratory results so that apparent progress in one measure does not hide deterioration elsewhere.